About this scholarly article

Phase I and Pharmacokinetic Study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese Patients with Solid Tumors by Yamamoto, N.; Yamada, Y.; Fujiwara, Y.; Yamada, K.; Fujisaka, Y.; Shimizu, T.; Tamura, T. is a scholarly article available to read on EtoBox.

Author

Yamamoto, N.; Yamada, Y.; Fujiwara, Y.; Yamada, K.; Fujisaka, Y.; Shimizu, T.; Tamura, T.

Publisher

Oxford University Press; Oxford University Press (OUP) (ISSN 0368-2811)

Published

2009